CNB. Research, development, innovation. 2013/2014

In the past two years we have faced a number of important ups and downs. In 2014, we lamented the passing away of Juan Pablo Albar, in whom we lost a great colleague and the scientist who put our centre on the international map of proteomics research. To some extent, Juan Pablo’s widely known capacity to pursue his goals with unswerving determination also represents the attitude our centre has had to adopt in the face of an unprecedented economic crisis; it would otherwise be difficult to explain how, despite severe cuts in research funding, the CNB has succeeded in preserving its vitality and ability to produce world class science. When we compare our revenues to the income we had in 2010, we have withstood a net reduction of 10 million euros over the past four years. The efforts of our scientists to pursue their research with these reduced resources have nonetheless made it possible to maintain the quality of our centre’s work. For the biennium 2013-2014, the Scopus database registered the exceptional number of 528 scientific publications signed by CNB scientists, 489 in JCR-indexed journals. This represents both a quantitative and qualitative increase. In 2014, 44% of these publications corresponded to the top 10% of high-impact journals in their respective fields of knowledge, which exceeds the centre’s five-year average by 8 percentage points. Highlights such as the ERC Advanced Grants to Víctor de Lorenzo and Víctor Muñoz, the inclusion of Roberto Solano in Thompson Reuter’s 2014 ranking of the top 1% of the world’s most highlycited scientists, or the award of the Mexico Prize for Science and Technology 2014 to Carlos Martínez-A, further reflect the scientific leadership of our researchers...Peer reviewe